Today, we at BAST were very pleased to see the press-release that the FDA granted accelerated approaval to Aliqopa (copanlisib) for which we delivered the pharmacometrics reports for the clinical pharmacology package. It always feels good to end the week with some positive news!
We at BAST GmbH are delighted to announce that we have moved into our new office at the Technologie Park in Heidelberg on September 1st. The office itself may still look a little spartan but our IT is fully set up with direct access to our main computing facilities at BAST Inc. that allow us to deliver state-of-the-art modelling and simulation work on time.
Here in Heidelberg, we look forward to the vibrant Biotech scene as well as the stimulating academic environment that awaits us.